Connection
Anosheh Afghahi to Receptor, ErbB-2
This is a "connection" page, showing publications Anosheh Afghahi has written about Receptor, ErbB-2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.186 |
|
|
|
-
Afghahi A, Sledge GW. Targeted Therapy for Cancer in the Genomic Era. Cancer J. 2015 Jul-Aug; 21(4):294-8.
Score: 0.106
-
Vemuru S, Huang J, Colborn K, Yoon Y, Huynh V, Leonard L, Ahrendt G, Christian N, Afghahi A, McLemore L, Sams S, Tevis S. Clinical implications of receptor conversions in breast cancer patients who have undergone neoadjuvant chemotherapy. Breast Cancer Res Treat. 2023 Jul; 200(2):247-256.
Score: 0.046
-
Weiss J, Afghahi A, Shagisultanova E, Diamond JR. Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer. Oncology (Williston Park). 2018 Oct 15; 32(10):513-5.
Score: 0.033